News & Press Releases
NEWS
Presentation of Saturn at TCT – October 2024
At TCT2024 on Tuesday, October 29, Dr. Torsten Vahl from Columbia University Irving Medical Center reviewed the first 3 patients in CASSINI-EU EFS study on Saturn Trans-septal TMVR System in the presentation ‘Novel TMVR Systems on the Launchpad’ during ‘TCT Innovation...
SATURN Transapical Early Feasibility in Annals of Thoraric Surgery Short Reports
Annals of Thoracic Surgery Short Reports just published Early Feasibility Study with the SATURN Transapical Mitral Valve Replacement Device, available at https://doi.org/10.1016/j.atssr.2024.06.011. Deep gratitude and congratulation to the authors: Prof. Kęstutis...
Presentation of Saturn and First-in-Human TS at NY Valves – June 2024
Our technology and first trans-septal implant have been presented at NY Valves 2024 held on June 5-7 in Jacob K. Javits Convention Center, New York. Specifically, Dr. Lauren S. Ranard, MD from Columbia University Irving Medical Center, held a presentation named...
Saturn TMVR System in Eurointervention
Eurointervention, the official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), published preclinical data on our novel, investigational Saturn TMVR device in the article Procedural performance and healing response...
Animation of the Saturn TMVR System Trans-septal Procedure
🎥 Watch our animation that showcases the trans-septal implant procedure of the Saturn TMVR system here. The Saturn device has a 29 French Valve Delivery System and 2 valve sizes (28 and 31mm) designed to anchor to the native mitral valve through a subannular ring at...
PRESS RELEASES
First-In-Human Trans-Septal Implantation of Saturn Mitral Valve Replacement
We are pleased to announce the first trans-septal clinical trial implant with our proprietary Saturn Transcatheter Mitral Valve. Excellent hemodynamic results are reported for the patient, a 79 year old female suffering from severe mixed (degenerative and functional)...
InnovHeart appoints David Wilson as Chief Executive Officer
Industry Leader to Guide Company and the Saturn TMVR Programin its Next Phase of Growth InnovHeart s.r.l. announced today the appointment of David James Wilson, an experienced healthcare and medical device executive as Chief Executive Officer of the company and...
InnovHeart raises $55 million in Series C financing to further develop the Trans-septal Saturn Transcatheter Mitral Valve Replacement System
InnovHeart and Grand Pharmaceutical Group Enter Into an Exclusive License Agreement to Develop and Commercialize the Saturn TMVR Device in Greater China Milan, January 27, 2022 - InnovHeart s.r.l. announces the closing of its Series C financing with granting an...
Azin Parhizgar, Ph.D. Joins InnovHeart as Independent Member of the Board of Directors
InnovHeart s.r.l., a developer of novel Transcatheter Mitral Valve Replacement (TMVR) systems for the treatment of Mitral Regurgitation, announced today the appointment of successful serial entrepreneur and medical device executive Dr. Azin Parhizgar, Ph.D. as an...
InnovHeart Reports Successful First-in- Human Implantation of its Saturn Transcatheter Mitral Valve with Excellent 30-day Follow-up
InnovHeart s.r.l., a developer of novel Transcatheter Mitral Valve Replacement (TMVR) systems for the treatment of Mitral Regurgitation (MR), announced today the successful Firstin-Human implantation of its proprietary Saturn Transcatheter Mitral Valve along with...